151 related articles for article (PubMed ID: 17634201)
1. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.
Lo CC; Davidson WS; Hibbard SK; Georgievsky M; Lee A; Tso P; Woods SC
Endocrinology; 2014 May; 155(5):1700-7. PubMed ID: 24564397
[TBL] [Abstract][Full Text] [Related]
3. Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.
Yoshimichi G; Lo CC; Tamashiro KL; Ma L; Lee DM; Begg DP; Liu M; Sakai RR; Woods SC; Yoshimatsu H; Tso P
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1336-42. PubMed ID: 22461023
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration.
Lo CM; Xu M; Yang Q; Zheng S; Carey KM; Tubb MR; Davidson WS; Liu M; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R43-50. PubMed ID: 19020287
[TBL] [Abstract][Full Text] [Related]
5. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.
Lo CC; Langhans W; Georgievsky M; Arnold M; Caldwell JL; Cheng S; Liu M; Woods SC; Tso P
Endocrinology; 2012 Dec; 153(12):5857-65. PubMed ID: 23027805
[TBL] [Abstract][Full Text] [Related]
7. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
Corp ES; Curcio M; Gibbs J; Smith GP
Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
9. Proglumide fails to increase food intake after an ingested preload.
Schneider LH; Gibbs J; Smith GP
Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
[TBL] [Abstract][Full Text] [Related]
10. CCK-58 prolongs the intermeal interval, whereas CCK-8 reduces this interval: not all forms of cholecystokinin have equal bioactivity.
Sayegh AI; Washington MC; Raboin SJ; Aglan AH; Reeve JR
Peptides; 2014 May; 55():120-5. PubMed ID: 24607725
[TBL] [Abstract][Full Text] [Related]
11. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
Volkoff H; Eykelbosh AJ; Peter RE
Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
Hayes MR; Savastano DM; Covasa M
Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis.
Ebenezer IS
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):167-71. PubMed ID: 10389118
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine.
Tso P; Chen Q; Fujimoto K; Fukagawa K; Sakata T
Obes Res; 1995 Dec; 3 Suppl 5():689S-695S. PubMed ID: 8653550
[TBL] [Abstract][Full Text] [Related]
15. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
16. Role for the cholecystokinin-A receptor in fever: a study of a mutant rat strain and a pharmacological analysis.
Ivanov AI; Kulchitsky VA; Romanovsky AA
J Physiol; 2003 Mar; 547(Pt 3):941-9. PubMed ID: 12562931
[TBL] [Abstract][Full Text] [Related]
17. The role of brain-gut peptides in the control of sodium appetite.
Edwards GL; Power JD
Ann N Y Acad Sci; 1999; 897():192-7. PubMed ID: 10676448
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway.
Glatzle J; Darcel N; Rechs AJ; Kalogeris TJ; Tso P; Raybould HE
Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R354-9. PubMed ID: 15117731
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats.
Lindén A; Södersten P
Physiol Behav; 1990 Dec; 48(6):859-63. PubMed ID: 2087518
[TBL] [Abstract][Full Text] [Related]
20. Synergy between amylin and cholecystokinin for inhibition of food intake in mice.
Bhavsar S; Watkins J; Young A
Physiol Behav; 1998 Jun; 64(4):557-61. PubMed ID: 9761232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
